Thrombosis of the brachiocephalic veins or superior vena cava (SVC) is rare. This study was conducted to determine the prevalence and characteristics of thrombosis of brachiocephalic veins and SVC , and its association with symptomatic pulmonary embolism (PE). The prevalence of thrombosis involving the brachiocephalic veins and SVC was evaluated retrospectively at a university hospital during the 3-year period. Patients were identified by hospital records and review of computer-generated lists of of all venograms, contrastenhanced chest computed tomography, and magnetic resonance angiograms of the upper extremity and SVC. Thrombosis of the brachiocephalic veins and SVC was diagnosed in 33 (0.03 %) of 100,942 patients of all ages [(32 of 70,751 adult patients ≥ 20 years; 0.04%)]. Twenty-three (70%) patients initially had secondary thrombosis with multiple risk factors: associated with malignancy in 14 (42%) patients, chronic disorders in 13 (39%) patients, central venous lines (CVL) and peripheral venous lines (PVL) in 9 (27%) patients, and thrombophilia in 10 (38%) of 26 patients. Swelling of the arm, head, and neck was present in 32 (97%) patients. Symptomatic PE developed before thrombosis being treated in 12 (36%) patients. All patients except eight (three, thrombolytic; five, thrombectomy) received anticoagulant therapy. Thrombosis of the SVC and brachiocephalic veins is an uncommon but serious complication in patients with malignancy, chronic disorders, CVL, PVL, and thrombophilia. Because it is important clinical problem with frequent PE, the patients with appropriate clinical findings should be diagnosed early with imaging tests and treated with anticoagulant drugs.
Thromboembolic diseases of the superior vena cava (SVC) and brachiocephalic veins or both are an important clinical problem that requires prompt diagnosis. It has rarely been reported previously (1) (2) (3) (4) (5) .
Thrombosis of SVC is a rare cause of SVC syndrome (1, 3) . Occlusion of the central thoracic veins is one of the most frequent and severe complications of central venous access lines (CVL) and cardiac pacemakers (2, 6, 7) . The association of clinically recognized pulmonary embolism (PE) with thrombosis of the SVC and/or brachiocephalic veins has previously been reported in patients with CVL (6) , transvenous pacing (7) , or in some case reports (2, 8, 9) . Otten and colleagues (5) , recently observed two patients with non-fatal PE among 23 patients with thrombosis of the SVC and brachiocephalic veins.
In view of the more frequent use of CVL (6, (10) (11) (12) , cardiac pacemakers (7) , and new imaging tests for observation of the central thoracic veins (13) , it would seem that the number of hospitalized patients with thromboembolic disease of brachiocephalic veins or SVC should be higher than is generally recognized. We reviewed the frequency of diagnosis, the prevalence of associated PE, and the characteristics of thromboembolic disease involving the brachiocephalic veins and SVC at a university hospital.
MATERIALS AND METHODS
We conducted a retrospective study to evaluate the frequency of diagnosis in patients with thrombosis of brachiocephalic veins (innominate) or SVC at Erciyes University Medical School between January 1, 2001 and December 31, 2003 . Patients were identified by hospital records and review of computer-generated lists of all venograms, and contrast-enhanced chest computed tomography (CT) and magnetic resonance angiograms (MRA) of the SVC and upper extremity. The reports of each patient were reviewed, and cases with positive findings were included in the study. If the patient had been hospitalized on more than one occasion for brachiocephalic veins or SVC, only the relevant data from the first hospitalization were included.
We searched hospital records and computergenerated lists for the presence of concomitant upper extremity deep venous thrombosis (UEDVT) and coincidental lower extremity deep venous thrombosis (LEDVT). Confirmation of the diagnosis of UEDVT was made by reviewing the medical records of each patient for a report of color flow doppler ultrasonography (CDU), contrast venography, or MRA. An objective verification of the diagnosis was required for all patients. All diagnoses of LEDVT were confirmed by CDU.
A diagnosis of PE was made on the basis of a high-probability interpretation of the ventilationperfusion lung scan or positive spiral CT findings in patients with symptoms that were suggestive of PE. The spiral CT required an intraluminal filling defect or the identification of an embolus obstructing a vessel for the diagnosis of PE.
Risk-factor assessment was performed by taking a detailed history and a follow-up patient questionnaire. Hypercoagulability tests for antithrombin III, protein C and S, activated protein-C resistance (the Leiden mutation of factor V), antiphospholipid antibody, and lupus anticoagulant taken at a mean of 3 months after the episode of thrombosis were performed according to standard methods.
Erciyes University Medical School Hospital is a university hospital with a reported census of 1305 patients. It has a Cancer Center with a census of 90 patients and Renal Dialysis and Transplantation Center with a census of 105 patients.
RESULTS
During the 3-year period, 100,942 patients were admitted to the hospital, including new-borns. Thromboembolic disease of the brachiocephalic veins or SVC was diagnosed in 33 of 100,942 patients of all ages (0.03%). Of the 33 patients, one was 17-year-old male with SVC thrombosis and right atrial thrombus associated with chronic renal failure (CRF) and CVL. The prevalence of the brachiocephalic veins or SVC in adults 20 years or older was 32 of 70,751 patients (0.04%).
We identified 91 patients as having UEDVT during this period. In 25 patients (27%), the UEDVT was shown with venography ( Fig. 1 ) or MRI to extend to the brachiocephalic veins and 11 (12%) had extension to the SVC. In two of 25 patients, initial UEDVT recurred to extend to the brachiocephalic vein and SVC after intravenous (IV) chemotherapeutic and anesthetic drug injection via CVL and PVL aproximately 1 year later. Seven of 70,751 adult patients (0.01%) had thrombosis of the SVC or brachiocephalic vein, unaccompanied by UEDVT and LEDVT. In addition to these patients, one patient had thrombosis of the SVC and brachiocephalic vein, accompanied by LEDVT.
Among all patients with thromboembolic diseases including the brachiocephalic veins or SVC, 22 (67%) were male, and 11 (33%) were female. Table 1 .
Twelve (36%) of the 33 patients had symptomatic PE. Four had fatal PE. PE occurred before venous thrombosis was diagnosed and treated in all patients. Seven patients with PE and thrombosis of the brachiocephalic vein and SVC also had UEDVT. Four patients with PE also had right atrial thrombus. No patients with PE had coincidental LEDVT. Four patients with PE (33%) were diagnosed with high-probability ventilation-perfusion lung scans, while eight (66%) were diagnosed with contrast-enhanced spiral CT.
The signs and symptoms observed in all patients except one are given in Table 1 . One patient with isolated partial SVC thrombosis because of Behçet's disease had no symptoms. Duration of symptoms before treatment was 11.2±10.5 days (range, 1-30 days). Unilateral or bilateral arm swelling, pain, neck and face edema were the most common complaints in 32 (97%) patients. Eight women with thrombosis of the brachiocephalic veins and SVC had prominent ipsilateral breast edema.
The clinical variants and etiologic risk factors of the patients with thromboembolic diseases including the brachiocephalic veins and SVC are shown in Table 2 . Ten (30%) patients had no previous underlying disease or risk factor before thrombosis and were classified as primary or id-iopathic. Twenty-two (70%) patients had associated diseases and conditions such as malignancy, chronic medical diseases, cardiac pace makers, IV fluid and drug injection via CVL, and peripheral venous lines (PVL). All patients with secondary UEDVT had at least two or more inherited or acquired risk factors.
In 10 patients with primary thrombosis, Effort thrombosis (Paget-Schroetter syndrome) was identified in two (6%) patients after strong efforts with the arms. There were two patients with antiphospholipid antibody syndrome with anticardiolipin antibody positivity among the patients with idiopathic thrombosis.
Cancer was diagnosed in 14 (42%) patients. Eleven (79%) had pleural and pulmonary malignancy (lung carcinoma and mesothelioma). Thirteen patients (92%) had external compression (thoracic outlet syndrome) due to primary cancer or metastasized lymphadenopathy in the thoracic outlet. Six (18%) of these cases were classified as primary thrombosis with occult cancer. These patients were admitted with signs suggestive of SVC syndrome or UEDVT and the malignancy was detected later.
Ten (33%) patients with brachiocephalic vein thrombosis and SVC thrombosis were associated with cardiac pacemakers, CVL, and PVL. CVL had been inserted in four (12%) patients, and only one (3%) also had cancer. One case was associated with a cardiac pacemaker. There were six (18%) patients with chronic lung disease and cor pulmonale, (4 [12%] of them had chronic obstructive pulmonary disease [COPD] and two patients with cardiac disease) associated with secondary thrombosis. The majority of patients with PVL had previously received IV infusions of medications. Their medical histories revealed severe coughing bouts, frequent acute exacerbation, high hematocrit levels, and frequent hospitalization.
Six (18%) patients with brachiocephalic vein thrombosis and subclavian vein thrombosis had arteriovenous (AV) shunts and CVL for renal hemodialysis. One also had Buerger's disease. There was no evidence of thrombosis of the shunts. Three patients had Behçet's disease associated with secondary thrombosis in our patients. All of them were diagnosed as having Behçet's disease but they did not receive any immunosupressive therapy before thrombosis.
Thrombophilia was found in 10 (38%) of the 26 patients with primary and secondary thrombosis (Table 1) . Two had primary UEDVT with no associated diseases, while eight patients with thrombophilia had secondary UEDVT with underlying diseases. APC resistance in three patients (9%) and lupus anticoagulant activity in three patients (9%) were the most common coagulation abnormality among the patients given hypercoagulability tests. Three patients with malignancy also had anticardiolipin antibody positivity in two and lupus anticoagulant activity in one.
All the patients except the eight with brachiocephalic vein thrombosis and SVC thrombosis received therapy with anticoagulant agents. None of the patients with malignancy and chronic medical diseases with or without CVL and PVL had regularly received anticoagulant prophylaxis before thrombosis. Three (9%) patients received IV streptokinase followed by heparin and None (incidental finding) 1 3
Thrombophilic states (N = 26)
APC Resistance 3 12
Antithrombin-3 deficiency 1 4
ACL-Abs 2 8
Protein-S deficiency 1 4
Lupus anticoagulant 3 12
APC resistance: activated protein C resistance; ACL-Abs: anticardiolipin antibodies; CNS: central nervous system; SVC: superior vena cava.
warfarin. Thirteen (39%) patients were treated with unfractioned dose-adjusted heparin followed by warfarin for at least 3 to 6 months. Twelve (36%) patients were treated with a lowmolecular-weight heparin (LMWH) (deltaparine at a dosage of 200 U/kg or enoxaparine 1.5 mg/kg per day, subcutaneously) followed by warfarin sodium for at least 3 to 6 months. Thrombectomy, performed in five renal dialysis patients with thrombosis of the brachiocephalic vein and SVC was another treatment modality with anticoagulant therapy. Two of them also had right atrial thrombus. Surgery was successful in all patients.
DISCUSSION
Thirty-three patients with thrombosis of a brachiocephalic vein or SVC were identified. Twelve (36%) of the 33 patients had objectively diagnosed symptomatic PE. Many of the patients with PE also had UEDVT or right atrial thrombus in accordance with previous reports (5) (6) (7) (8) . Most PE (94%) in patients with thrombosis was reported in untreated patients (14) . In addition, PE in all patients had occurred before the venous thrombosis was treated in our series. Two patients with non-fatal PE associated with thrombosis of a brachiocephalic vein or SVC have recently been reported by Otten and colleagues (5) .
The signs and symptoms of thrombosis of the brachiocephalic vein and SVC have features in common with the SVC syndrome as well as UEDVT (5) . Swelling of the upper extremity and pain in the arm were the most common complaints in our study. Forty-two percent of all patients also presented with symptoms of SVC syndrome. Kee and colleagues (11) reported 59 patients with SVC syndrome: 20% were associated with CVL and pacemakers. Breast edema was observed in eight of 11 women in our series as a physical finding which has previously been discussed in central thoracic vein obstructions (15) .
Thrombosis of the SVC is a recognized cause of SVC syndrome (1, 3, 9) . PE due to thrombosis of the SVC usually resulted in mortality in some cases (6,7); however, some living patients have been reported (8, 11, 16) . Adelstein and colleagues (16) previously suggested that SVC Chronic lung disease and core pulmonale 5 15
Cardiac disease 2 6
Behçet's disease 3 9
Ankylosing spondylitis and Sapho syndrome 1 3
Electric shock 1 3
IV drug injection (chemotherapetic or anesthetic) 4 12
Thrombophilic states 10 /26 (total) 38 A-V: arteriovenous; CVL: central venous access lines; PVL: peripheral venous lines; CRF: chronic renal failure.
thrombosis may pose a significant risk for PE in patients with SVC syndrome due to malignancy. Also PE with brachiocephalic vein thrombosis with or without mortality have been reported in some patients with CVL and cardiac pacemakers (2, (4) (5) (6) (7) 9) . Whether the frequency of diagnosing brachiocephalic vein thrombosis or SVC thrombosis, which we observed among hospitalized patients, is representative of other hospitals is uncertain. There is only one hospital to which to compare our findings. Otten and colleagues (5) reported thromboembolic disease of the brachiocephalic vein or SVC diagnosed in 23 of 34,567 hospitalized adults (0.06%) who were 20 years of age or older. The prevalence of thrombosis of brachiocephalic veins and SVC thrombosis that we observed among hospitalized patients was slightly lower than that reported by Otten and colleagues (5) . This finding may be related to the more frequent use of CVL in Otten and colleagues' series (5) .
The use of CVL and its role in the thrombosis of the great veins of the thorax (10, 11, 17, 18) became apparent in chronically ill patients, particularly those with end-stage renal disease (19) . In our study, 25% of the patients had CVL and PVL, whereas in Otten's study (5) , 65% had CVL. There were six renal hemodialysis patients in our series. Their thrombosis were associated with CVL and patent arteriovenous shunts with the thrombosis of brachiocephalic and subclavian veins. Central thoracic venous thrombosis in patients undergoing hemodialysis is thought to originate from high blood flow from arteriovenous fistulas, and occurs at sites of turbulence, such as valves (19, 20) . There were four patients with secondary thrombosis due to COPD in our series in contrast to Otten's series (5) . Ashitani and colleagues (21) showed an enhanced prothrombotic process in patients with COPD, which could potentially account for the increased thrombosis in vessels in these patients.
Arterial and, more commonly, venous thrombosis is a frequent complication of cancer and sometimes a harbinger of occult cancer (22) . Six (18%) patients with occult cancer presented with signs suggestive of SVC syndrome or UEDVT and the malignancy was detected later. There are many causes of thrombosis in cancer (22) . Thrombosis may result from direct invasion of the vein by the tumor, compression of the vein by neoplasm, or a hypercoagulable state associated with malignancy or therapy (23, 24) . These factors, alone or in combination with CVL, surgery, and radiation therapy predispose pa-tients with cancer to thrombosis. Cancer was diagnosed in 42% of all patients, similar to Otten and colleagues' series (5) .
External compression (thoracic outlet syndrome) due to primary cancer or metastasized lympadenopathy accounted for 90% of the cases malignancy-related thrombosis.
Three patients had Behçet's disease among our patients in contrast to Otten's series (5) . Involvement of major veins including occlusion of the SVC may be associated with thrombosis of subclavian veins or innominate veins in Behçet's disease (25) .
A hypercoagulable state may also be associated with thrombosis (26). Ellis and colleagues (26) studied 18 patients with UEDVT and identified a thrombophilic state in 11 (61%). We investigated the patients for a thrombophilic state, which was found in 38% of 26 patients.
We diagnosed isolated thromboembolic disease of the brachiocephalic veins or SVC in 32 of 70,751 of adult patients 20 years of age or older (0.04%). The frequency of isolated thrombosis of the SVC or brachiocephalic veins that we reported probably grossly underestimates the true incidence, because imaging tests for central throracic veins are usually performed in symptomatic selected patients because CDU cannot depict the SVC and proximal segment of the brachiocephalic veins (27) (28) (29) (30) . Contrast venography is the most conclusive test (27) . Magnetic resonance imaging (MRI) (13, 29) , contrast-enhanced thorax CT (28) , and spiral CT phlebography (30) may be beneficial. If a patient has upper extremity symptoms (e.g., arm edema and pain) or SVC syndrome findings (e.g., face and neck edema) and has had CVL or PVL and/or cancer or chronic illness, one of these diagnostic tests may be indicated if the ultrasonography finding is negative or central venous obstruction is suspected
In conclusion, isolated thrombosis of the brachiocephalic veins and SVC is uncommon. Its etiology is usually secondary and associated with malignancy, CVL, PVL, chronic illness (cardiac, pulmonary, and renal diseases), and thrombophilia, or a combination. The signs and symptoms of thrombosis of the brachiocephalic veins and/or SVC have features in common with the SVC syndrome as well as UEDVT. Because the incidence of PE may result in an increased incidence in untreated patients with thrombosis of brachiocephalic veins and SVC, patients with appropriate clinical findings and risk factors should be evaluated with venography, contrast-enhanced CT, or MRI.
